PSD2 and colorectal carcinoma: The presence of fusion transcripts expressed at low levels are consistent with three fusion transcripts we recently identified in CRC, where AKAP13-PDE8A, COMMD10-AP3S1, and CTB-35F21.1-PSD2 were identified in 17–58% of 106 primary cancer tissues [12].